SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-016462
Filing Date
2010-03-25
Accepted
2010-03-25 15:54:15
Documents
3
Period of Report
2010-03-22
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-7027_18k.htm 8-K 31529
2 EX-99.1 a10-7027_1ex99d1.htm EX-99.1 14026
3 GRAPHIC g70271mmi001.gif GRAPHIC 5046
  Complete submission text file 0001104659-10-016462.txt   54344
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 10704620
SIC: 2834 Pharmaceutical Preparations